PAVmed Inc. (PAVM)

[MaineMan5]

Company submitted additional data in late July to FDA in support of CarpX and expects a decision the end of August to mid Sept (but could come any time). The new data provided additional support for approval of their device in the $1+ billion carpal tunnel market. They also have an improved device for collecting cells to look for cancer of the esophagus that they plan to take to FDA for approval late this year (also a $1+ billion market). They are well funded and indicate no new raises are necessary to launch these two devices. They also have others in their pipeline. Below is a good update by management yesterday. I am very high on this company at $1.40 as if both devices get approved (and it is easier to get a device approved than a drug), this could be a 10 or 20 bagger in a year or so. If one or both don't get approved or are delayed, stock could take a hit but I view this as an outsized reward / risk situation. JMO.

https://finance.yahoo.com/news/pavmed-reports-second-quarter-2018-113000387.html